Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -324.69 | 48.07 |
| PEG Ratio (TTM) | -3.54 | 1.86 |
| P/S Ratio (TTM) | 2.71 | 1.47 |
| P/B Ratio (TTM) | 2.46 | 4.15 |
| P/FCF Ratio (TTM) | 11.08 | 15.58 |
| Price to 5YR AVG Earnings Ratio | -19.59 | -71.55 |
| Price to 5YR AVG FCF Ratio | 21.96 | 17.71 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.20% | 1.73% |
| ROE (TTM) | -0.78% | 19.47% |
| Net Profit Margin (TTM) | -0.83% | -6.13% |
| ROIC 5YR AVG | -7.31% | 18.50% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 70.04% | 48.83% | -39,194.58% |
| Revenue | 2.98% | 59.50% | 41.82% |
| Net Income | 72.43% | 16.40% | -40,113.98% |
| Cash Flow | 24.93% | 417.49% | 263.18% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.10 | 1.28 |
| Quick Ratio (TTM) | 1.10 | 1.27 |
| D/E Ratio (TTM) | 0.80 | 1.16 |
| Interest Coverage (TTM) | 0.43 | -0.80 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.51 | 1.99 |
| LTL to 5YR AVG FCF | 6.65 | 5.07 |
| Shares Outstanding Growth 5YR AVG | 25.42% | 16.40% |